A checkpoint on innate myeloid cells in pulmonary arterial hypertension
Main Authors: | Andrew J. Bryant, Chunhua Fu, Yuanquing Lu, Mark L. Brantly, Borna Mehrad, Lyle L. Moldawer, Todd M. Brusko, Evan L. Brittain, James D. West, Eric D. Austin, Rizwan Hamid |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894018823528 |
Similar Items
-
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
by: Andrew J. Bryant, et al.
Published: (2018-08-01) -
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
by: Tracy C. Kuo, et al.
Published: (2020-11-01) -
Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness
by: Grant Barker, et al.
Published: (2021-04-01) -
Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid Leukemia
by: Matthew R. Lordo, et al.
Published: (2021-01-01) -
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
by: Silvia Pesce, et al.
Published: (2020-11-01)